John N. Flanagan

2.8k total citations
44 papers, 2.0k citations indexed

About

John N. Flanagan is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, John N. Flanagan has authored 44 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Pathology and Forensic Medicine and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in John N. Flanagan's work include Vitamin D Research Studies (12 papers), Hormonal and reproductive studies (8 papers) and Sexual Differentiation and Disorders (7 papers). John N. Flanagan is often cited by papers focused on Vitamin D Research Studies (12 papers), Hormonal and reproductive studies (8 papers) and Sexual Differentiation and Disorders (7 papers). John N. Flanagan collaborates with scholars based in United States, Sweden and Cyprus. John N. Flanagan's co-authors include Mark W. Nachtigal, Holly A. Ingraham, Yoshifumi Hirokawa, Gary D. Hammer, Tai C. Chen, Michael F. Holick, Lyman W. Whitlatch, Leonard Gibbs, Shalender Bhasin and Lilin Wang and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

John N. Flanagan

43 papers receiving 1.9k citations

Peers

John N. Flanagan
Gary M. Leong Australia
Clara Crescioli Italy
Vanessa Dubois Belgium
Jorge N. Artaza United States
Miguel Ángel García‐Pérez Spain
Michael S. Kappy United States
Serap Turan Türkiye
Yong Gao China
Sirui Zhou China
Leah Holloway United States
Gary M. Leong Australia
John N. Flanagan
Citations per year, relative to John N. Flanagan John N. Flanagan (= 1×) peers Gary M. Leong

Countries citing papers authored by John N. Flanagan

Since Specialization
Citations

This map shows the geographic impact of John N. Flanagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John N. Flanagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John N. Flanagan more than expected).

Fields of papers citing papers by John N. Flanagan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John N. Flanagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John N. Flanagan. The network helps show where John N. Flanagan may publish in the future.

Co-authorship network of co-authors of John N. Flanagan

This figure shows the co-authorship network connecting the top 25 collaborators of John N. Flanagan. A scholar is included among the top collaborators of John N. Flanagan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John N. Flanagan. John N. Flanagan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Subramanian, N, Anna Wiik, Eric Rullman, et al.. (2024). Adipokine secretion and lipolysis following gender-affirming treatment in transgender individuals. Journal of Endocrinological Investigation. 47(9). 2249–2260. 3 indexed citations
2.
3.
Boström, Adrian E. Desai, Andreas Chatzittofis, Diana M. Ciuculete, et al.. (2019). Hypermethylation-associated downregulation of microRNA-4456 in hypersexual disorder with putative influence on oxytocin signalling: A DNA methylation analysis of miRNA genes. Epigenetics. 15(1-2). 145–160. 20 indexed citations
4.
Wiik, Anna, Tommy R. Lundberg, Eric Rullman, et al.. (2019). Muscle Strength, Size, and Composition Following 12 Months of Gender-affirming Treatment in Transgender Individuals. The Journal of Clinical Endocrinology & Metabolism. 105(3). e805–e813. 67 indexed citations
5.
Wiik, Anna, Daniel P. Andersson, Torkel B. Brismar, et al.. (2018). Metabolic and functional changes in transgender individuals following cross-sex hormone treatment: Design and methods of the GEnder Dysphoria Treatment in Sweden (GETS) study. Contemporary Clinical Trials Communications. 10. 148–153. 31 indexed citations
6.
Jokinen, Jussi, Adrian E. Desai Boström, Andreas Chatzittofis, et al.. (2017). Methylation of HPA axis related genes in men with hypersexual disorder. Psychoneuroendocrinology. 80. 67–73. 29 indexed citations
7.
Chiang, Kun‐Chun, Chun‐Nan Yeh, Jun‐Te Hsu, et al.. (2013). MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase. The Journal of Steroid Biochemistry and Molecular Biology. 138. 427–434. 34 indexed citations
8.
Frøkiær, Hanne, Stine Broeng Metzdorff, Gudrun Weiss, et al.. (2012). Astragalus Root and Elderberry Fruit Extracts Enhance the IFN-β Stimulatory Effects of Lactobacillus acidophilus in Murine-Derived Dendritic Cells. PLoS ONE. 7(10). e47878–e47878. 18 indexed citations
9.
Iglesias‐Gato, Diego, Shasha Zheng, John N. Flanagan, et al.. (2011). Substitution at carbon 2 of 19-nor-1α,25-dihydroxyvitamin D3 with 3-hydroxypropyl group generates an analogue with enhanced chemotherapeutic potency in PC-3 prostate cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 127(3-5). 269–275. 26 indexed citations
10.
Getty‐Kaushik, Lisa, Jason Viereck, Zifang Guo, et al.. (2009). Mice Deficient in Phosphofructokinase‐M Have Greatly Decreased Fat Stores. Obesity. 18(3). 434–440. 7 indexed citations
11.
Gupta, Vandana, Shalender Bhasin, Wen Guo, et al.. (2008). Effects of dihydrotestosterone on differentiation and proliferation of human mesenchymal stem cells and preadipocytes. Molecular and Cellular Endocrinology. 296(1-2). 32–40. 134 indexed citations
12.
Flanagan, John N., et al.. (2008). Expression of Cytokeratin 19 in the Diagnosis of Thyroid Papillary Carcinoma by Quantitative Polymerase Chain Reaction. Endocrine Practice. 14(2). 168–174. 9 indexed citations
13.
14.
Webb, Dominic‐Luc, Vera Schultz, John N. Flanagan, et al.. (2007). Tissue-dependent loss of phosphofructokinase-M in mice with interrupted activity of the distal promoter: impairment in insulin secretion. American Journal of Physiology-Endocrinology and Metabolism. 293(3). E794–E801. 17 indexed citations
15.
Wang, Lilin, et al.. (2004). Regulation of 25-hydroxyvitamin D-1α-hydroxylase by epidermal growth factor in prostate cells. The Journal of Steroid Biochemistry and Molecular Biology. 89-90(1-5). 127–130. 14 indexed citations
16.
Wang, Lilin, Lyman W. Whitlatch, John N. Flanagan, Michael F. Holick, & Tai C. Chen. (2003). Vitamin D Autocrine System and Prostate Cancer. Recent results in cancer research. 164. 223–237. 13 indexed citations
17.
Whitlatch, Lyman W., Gary G. Schwartz, John N. Flanagan, et al.. (2002). 25-Hydroxyvitamin D-1α-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer. The Journal of Steroid Biochemistry and Molecular Biology. 81(2). 135–140. 79 indexed citations
18.
Chen, Tai C., et al.. (2001). Enhancing 1α-Hydroxylase Activity with the 25-Hydroxyvitamin D-1α-Hydroxylase Gene in Cultured Human Keratinocytes and Mouse Skin. Journal of Investigative Dermatology. 116(6). 910–914. 11 indexed citations
19.
Nachtigal, Mark W., et al.. (1998). Wilms' Tumor 1 and Dax-1 Modulate the Orphan Nuclear Receptor SF-1 in Sex-Specific Gene Expression. Cell. 93(3). 445–454. 471 indexed citations
20.
Bayne, E K, John N. Flanagan, B. Azzolina, et al.. (1997). Dose-dependent and long term effects of RU58841 (androgen receptor blocker) on hair growth in the bald stumptailed Macaque.. Journal of Investigative Dermatology. 4(108). 651. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gary M. Leong Breakdown of academic impact, for papers by Clara Crescioli Breakdown of academic impact, for papers by Vanessa Dubois Breakdown of academic impact, for papers by Jorge N. Artaza Breakdown of academic impact, for papers by Miguel Ángel García‐Pérez Breakdown of academic impact, for papers by Michael S. Kappy Breakdown of academic impact, for papers by Serap Turan Breakdown of academic impact, for papers by Yong Gao Breakdown of academic impact, for papers by Sirui Zhou Breakdown of academic impact, for papers by Leah Holloway
Rankless by CCL
2026